Transparency
Market Research Reports included a detailed market survey and analysis trends
on “Ulcerative Colitis Therapeutics
Market”. This report also includes more info about basic overview of
the industry including definitions, applications and global market industry
structure.
Ulcerative
colitis is a chronic idiopathic inflammatory bowel disease (IBD) of the
gastrointestinal tract that affects the mucosal lining of the colon commonly
occur in people aged between 15-30 years. Ulcerative colitis is one of the 2
major types of IBD along with Crohn’s disease. Unlike Crohn’s disease, which
can affect any part of the gastrointestinal tract, ulcerative colitis
characteristically involves only the large bowel. The actual cause of the
disease is still unidentified but with the available information it may be the
result of an over reactive immune response to normal bacteria and other
substances in the gastrointestinal tract.
Browse
Full Report with TOC: http://www.transparencymarketresearch.com/ulcerative-colitis-therapeutics-market.html
The
prominent symptoms of ulcerative colitis are abdominal pain and bloody diarrhea
due to inflammation and the development of open sores (ulcers) in the large
intestine (colon) and rectum. Other symptoms of ulcerative colitis include
abdominal cramping, nausea, fever, skin ulcers, loss of appetite, weight loss,
joint pain, and fatigue. Severe complications of ulcerative colitis include
hemorrhage, colon rupture, and the possible development of colon cancer. About
20% of people with ulcerative colitis have a family member with the disease or
with Crohn's disease which is also a type of IBD. There is no known cure for
ulcerative colitis till now, but therapies are available that may significantly
reduce the signs and symptoms of ulcerative colitis and even bring about a
long-term remission.
Therapeutics
market for ulcerative colitis can be segmented based upon drug classes:
- Aminosalicylates
- Sulfasalazine
- Mesalamine
- Balsalazide
- Corticosteroids
- Prednisone
- Methylprednisolone
- Immunomodulators
- ulcerative colitis
- Antibiotics
- Ampicillin
- Ciprofloxacin
- Other
The prevalence of
ulcerative colitis varies with the geographical location. According to the U.S.
Pharmacist Northern Europe, United Kingdom and North America have highest
reported disease incidences in past few years. The disease in U.S.
approximately affects 250,000 to 500,000 people annually. Although there are
few epidemiologic data from developing countries, the incidence and prevalence
of IBD are growing with time and in different regions around the world, indicating
its occurrence as a global disease.
Recent FDA approved
drugs include SIMPONI ARIA as an infusion treatment from Janssen Biotech, Inc.,
in July 2013, UCERIS from Santarus Inc., in Jan 2013, DELZICOL from Warner
Chilcott in April 2013, among others. Some of the leading drug manufacturer for
Ulcerative colitis includes Johnson & Johnson, Abbott Laboratories, Takeda
Pharmaceutical Company, Pfizer Inc., Janssen Biotech, Inc. among other.
Enquiry
before Buying @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2185
This research report
analyzes this market depending on its market segments, major geographies, and
current market trends. Geographies analyzed under this research report
include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides
comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming
years
This
report is a complete study of current trends in the market, industry growth
drivers, and restraints. It provides market projections for the coming years.
It includes analysis of recent developments in technology, Porter’s five force
model analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
Reasons for Buying this
Report
- This report provides pin-point
analysis for changing competitive dynamics
- It provides a forward looking
perspective on different factors driving or restraining market
growth
- It provides a technological growth
map over time to understand the industry growth rate
- It provides a seven-year forecast
assessed on the basis of how the market is predicted to grow
·
It
helps in making informed business decisions by having complete insights of
market and by making in-depth analysis of market segments
More Reports On Pharmaceutical
Market: -
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About
Us:-
Transparency
Market Research (TMR) is a market intelligence company providing global
business research reports and consulting services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking insights
for thousands of decision-makers.
TMR’s
experienced team of analysts, researchers, and consultants use proprietary data
sources along with various tools and techniques to gather and analyze
information. Our business offerings represent the latest and the most reliable
information which is indispensable for businesses to sustain their competitive
edge.
Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Browse
Market Researche Report:-
http://marketsresearchreports.wordpress.com/
0 comments:
Post a Comment